ReviewClinical advances in hematology & oncology : H&O2019

Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time.

Dickran Kazandjian et al.PubMed ↗Full text ↗

No numbers read from the abstract.